发明名称 |
mutante solúvel tnfrp75, proteína de fusão, sequências de dna, usos do mutante solúvel tnfrp75 e da proteína de fusão e composições farmacêuticas |
摘要 |
<p>A soluble tumor necrosis factor receptor 2 (TNFRII) mutant has an amino acid substitution at position 92Glu compared with the wild TNFRII. The mutant improves the cytotoxicity capacity of neutralizing TNFalpha and lymphotoxin. The mutant and fusion protein comprising it are useful for the treatment of TNFalpha and lymphotoxin related diseases.</p> |
申请公布号 |
BRPI0906044(A2) |
申请公布日期 |
2015.07.07 |
申请号 |
BR2009PI06044 |
申请日期 |
2009.01.12 |
申请人 |
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD;TAIZHOU FUDAN-ZHANGJIANG PHARMACEUTICAL CO., LTD |
发明人 |
YANJUN LIU;FANG WU;JINSONG WU;TONG YANG;YIJUN SHEN |
分类号 |
C07K14/715;A61K38/19;A61P19/02;A61P37/02;C07K19/00;C12N15/12;C12N15/62 |
主分类号 |
C07K14/715 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|